Ku Eu Jeong, Lee Dong-Hwa, Jeon Hyun Jeong, Park Frank, Oh Tae Keun
Department of Internal Medicine, Chungbuk National University Hospital, Cheongju-si, Republic of Korea.
Department of Internal Medicine, Chungbuk National University College of Medicine, Cheongju-si, Republic of Korea.
Diabetes Ther. 2021 Jan;12(1):159-170. doi: 10.1007/s13300-020-00947-2. Epub 2020 Oct 24.
A psychometric analysis on type 2 diabetic (T2D) patients was performed to assess whether glycated hemoglobin (HbA1c) levels were dependent upon either the psychologic or economic attitude toward the use of insulin as a treatment for their diabetic condition.
A cross-sectional study was designed using 271 patients with T2D who regularly visited a tertiary referral hospital in South Korea from June 2019 to December 2019. Each patient enrolled in this protocol was treated with insulin for at least 6 months, had recordings of their plasma HbA1c measurement, and completed validated questionnaires consisting of items focusing on patient attitudes toward insulin use [Insulin Treatment Appraisal Scale (ITAS)] and cost-related issues related to diabetic supply purchase. Multiple regression analyses were performed to determine the association between their HbA1c and each item on the questionnaires.
In both males and females, there was a significant association (P < 0.05) between HbA1c levels and multiple items on the ITAS questionnaire, which are generally regarded as a negative perception (ITAS 1 "personal failure" and ITAS 2 "illness severity" in males and ITAS 12 "expected harm" and ITAS 15 "restrictiveness" in females). In females, however, not all perceptions were negative, since one item (ITAS 8 "anticipated effect") was correlated with the measurement of a lower HbA1c level (- 0.495 ± 0.211, P < 0.05). There was no association between the levels of HbA1c and the cost of insulin or associated diabetic supplies. Since only a few patients in this study chose to reduce their drug dosing because of cost, the resistance to using insulin is likely not driven by economic reasons.
The psychometric results of the ITAS suggested that HbA1c levels were directly associated with a positive attitude of the patient to willingly use insulin for therapy. The cost of the insulin therapy was not associated with HbA1c levels. These findings in the Korean population suggest that continued education is needed to ensure that T2D patients have a reinforced positive psychology toward the use of insulin in the control of their glycemia.
对2型糖尿病(T2D)患者进行了心理测量分析,以评估糖化血红蛋白(HbA1c)水平是否取决于对使用胰岛素治疗糖尿病的心理或经济态度。
设计了一项横断面研究,纳入2019年6月至2019年12月期间定期前往韩国一家三级转诊医院就诊的271例T2D患者。纳入本研究方案的每位患者均接受胰岛素治疗至少6个月,有血浆HbA1c测量记录,并完成了经过验证的问卷,问卷项目聚焦于患者对胰岛素使用的态度[胰岛素治疗评估量表(ITAS)]以及与糖尿病用品购买相关的成本问题。进行多元回归分析以确定他们的HbA1c与问卷上每个项目之间的关联。
在男性和女性中,HbA1c水平与ITAS问卷上的多个项目之间均存在显著关联(P < 0.05),这些项目通常被视为负面认知(男性中的ITAS 1“个人失败”和ITAS 2“疾病严重程度”,女性中的ITAS 12“预期危害”和ITAS 15“限制性”)。然而,在女性中,并非所有认知都是负面的,因为一个项目(ITAS 8“预期效果”)与较低的HbA1c水平测量值相关(-0.495±0.211,P < 0.05)。HbA1c水平与胰岛素或相关糖尿病用品的成本之间没有关联。由于本研究中只有少数患者因成本原因选择减少药物剂量,因此对使用胰岛素的抵触可能不是由经济原因驱动的。
ITAS的心理测量结果表明,HbA1c水平与患者愿意使用胰岛素进行治疗的积极态度直接相关。胰岛素治疗的成本与HbA1c水平无关。韩国人群的这些发现表明,需要持续开展教育,以确保T2D患者在使用胰岛素控制血糖方面有强化的积极心态。